92 BIOLOGICAL EFFECTS OF LOW LEVEL EXPOSURES
of Chloroform-Induced Hepato- and Nephrotoxicity by Mirex and Kepone,”
Toxicol. Appl. Pharmacol. 48:509-517 (1979).- Hewitt, L. A., C. Palmason, S. Masson, and G. L. Plaa. “Evidence for the
Involvement of Organelles in the Mechanism of Ketone-Potentiated
Chloroform-Induced Hepatotoxicity,” Liver 10:35-48 (1990). - Purushotham, K. R., V. G. Lockard, and H. M. Mehendale. “Amplification
of Chloroform Hepatotoxicity and Lethality by Dietary Chlordecone in Mice,”
Toxicol. Pathol. 16:27-34 (1988). - Mehendale, H. M., K. R. Purushotham, and V. G. Lockard. “The Time-
Course of Liver Injury and 3H-Thymidine Incorporation in Chlordecone-
Potentiated CHC13 Hepatotoxicity,” Exp. Mol. Pathol. 51:31-47 (1989). - Mehendale, H. M., and V. G. Lockard. “Effect of Chlordecone on the Hepa
totoxicity of 1,1,2-Trichloroethylene and Bromobenzene,” Toxicologist 2:37
(1982). - Fouse, B. L., and E. Hodgson. “Effect of Chlordecone and Mirex on the
Acute Hepatotoxicity of Acetaminophen in Mice,” Gen. Pharmacol.
18:623-630 (1987). - Mehendale, H. M., and J. S. Klingensmith. “In Vivo Metabolism of CC14 by
Rats Pretreated with Chlordecone, Mirex or Phenobarbital,” Toxicol. Appl.
Pharmacol. 93:247-256 (1988). - Davis, M. E., and H. M. Mehendale. “Functional and Biochemical Correlates
of Chlordecone Exposure and Its Enhancement of CC14 Hepatotoxicity,” Toxi
cology 15:91-103 (1980). - Lockard, V. G., H. M. Mehendale, and R. M. O’Neal. “Chlordecone-Induced
Potentiation of Carbon Tetrachloride Hepatotoxicity: A Light and Electron
Microscopic Study,” Exp. Mol. Pathol. 39:230-245 (1983). - Lockard, V. G., H. M. Mehendale, and R. M. O’Neal. “Chlordecone-Induced
Potentiation of Carbon Tetrachloride Hepatotoxicity: A Morphometric and
Biochemical Study,” Exp. Mol. Pathol. 39:246-256 (1983). - Agarwal, A. K., and H. M. Mehendale. “CCl4-Induced Alterations in Ca2+
Homeostasis in Chlordecone and Phenobarbital Pretreated Animals,” Life Sci.
34:141-148 (1984). - Agarwal, A. K., and H. M. Mehendale. “Excessive Hepatic Accumulation of
Intracellular Ca2+ in Chlordecone Potentiated CC14 Toxicity,” Toxicology
30:17-24 (1984). - Carmines, E. L., R. A. Carchman, and J. F. Borzelleca. “Kepone: Cellular
Sites of Action,” Toxicol. Appl. Pharmacol. 49:543-550 (1979). - Agarwal, A. K., and H. M. Mehendale. “Effect of Chlordecone on Carbon
Tetrachloride-Induced Increase in Calcium Uptake in Isolated Perfused Rat
Liver,” Toxicol. Appl. Pharmacol. 83:342-348 (1986). - Kodavanti, P. R. S., U. P. Kodavanti, and H. M. Mehendale. “CCl4-Induced
Alterations in Hepatic Calmodulin and Free Calcium Levels in Rats Pretreated
with Chlordecone,” Hepatology 13:230-238 (1991). - Kodavanti, P. R. S., U. P. Kodavanti, and H. M. Mehendale. “Altered
Hepatic Energy Status in Chlordecone (Kepone) Potentiation of CC14 Hepato
toxicity,” Biochem. Pharmacol. 40:859-866 (1990). - Roberts, E., B. M. Ahluwalia, G. Lee, C. Chan, D. S. R. Sarma, and E.
Farber. “Resistance to Hepatotoxins Acquired by Hepatocytes during Liver
Regeneration,” Cancer Res. 43:28-34 (1983).